An Elevated Neutrophil-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Liver Cancer after Interventional Treatments

This study is aimed at examining the prognostic value of blood neutrophil-to-lymphocyte ratio (NLR) in patients with hepatocellular carcinoma (HCC). Demographic and clinical data of 543 HCC patients treated with interventional therapies were retrospectively analyzed. Preoperative NLRs were determine...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BioMed research international 2022-11, Vol.2022, p.1-8
Hauptverfasser:	Li, Xiaonan, Zhang, Yongsheng, Ma, Wei, Li, Jingwen
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Biomarkers Blood cell count Cancer therapies Care and treatment Cholangiocarcinoma Females Gender Health aspects Hepatectomy Hepatocellular carcinoma Hospitals Leukocytes (neutrophilic) Liver cancer Lymphocytes Measurement Medical prognosis Metastasis Multivariate analysis Neutrophils Patients Prognosis Risk analysis Risk factors Survival Survival analysis Transplants & implants Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study is aimed at examining the prognostic value of blood neutrophil-to-lymphocyte ratio (NLR) in patients with hepatocellular carcinoma (HCC). Demographic and clinical data of 543 HCC patients treated with interventional therapies were retrospectively analyzed. Preoperative NLRs were determined and receiver operating characteristic (ROC) curves were plotted for survival time in patients with high (NLR ≥3.8) and low (NLR3 mm), and NLR (>3.8) were risk factors for OST and PFST (P3.8) were independent risk factors for PFST (P
ISSN:	2314-6133 2314-6141
DOI:	10.1155/2022/6141317